1. Are ARBs now first‐line therapy for hypertension?. Issue 17 (9th September 2013) Authors: McInnes, Gordon Journal: Prescriber Issue: Volume 24:Issue 17(2013:Sep.) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Azilsartan (Edarbi): a new ARB for treating hypertension. Issue 5 (4th March 2013) Authors: Chaplin, Steve; McInnes, Gordon Journal: Prescriber Issue: Volume 24:Issue 5(2013:Mar.) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial. Issue 11 (18th November 2017) Authors: MacDonald, Thomas M.; Williams, Bryan; Webb, David J.; Morant, Steve; Caulfield, Mark; Cruickshank, J. Kennedy; Ford, Ian; Sever, Peter; Mackenzie, Isla S.; Padmanabhan, Sandosh; McCann, Gerald P.; Salsbury, Jackie; McInnes, Gordon; Brown, Morris J. Journal: Journal of the American Heart Association Issue: Volume 6:Issue 11(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension. Issue 8 (7th August 2015) Authors: Brown, Morris J; Williams, Bryan; MacDonald, Thomas M; Caulfield, Mark; Cruickshank, J Kennedy; McInnes, Gordon; Sever, Peter; Webb, David J; Salsbury, Jackie; Morant, Steve; Ford, Ian Journal: BMJ open Issue: Volume 5:Issue 8(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Issue 2 (February 2016) Authors: Brown, Morris J; Williams, Bryan; Morant, Steve V; Webb, David J; Caulfield, Mark J; Cruickshank, J Kennedy; Ford, Ian; McInnes, Gordon; Sever, Peter; Salsbury, Jackie; Mackenzie, Isla S; Padmanabhan, Sandosh; MacDonald, Thomas M Journal: Lancet Issue: Volume 4:Issue 2(2016) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mental Health Professionals' Positions in Relation to Advance Statements: A Foucauldian Discourse Analysis. (November 2021) Authors: Gumley, Andrew; Glasgow, Angela; McInnes, Gordon; Jackson, Calum Journal: Qualitative health research Issue: Volume 31:Number 13(2021) Page Start: 2378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial. Issue 8 (7th August 2015) Authors: MacDonald, Thomas M; Williams, Bryan; Caulfield, Mark; Cruickshank, J Kennedy; McInnes, Gordon; Sever, Peter; Webb, David J; Mackenzie, Isla S; Salsbury, Jackie; Morant, Steve; Ford, Ian; Brown, Morris J Journal: BMJ open Issue: Volume 5:Issue 8(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension. Issue 8 (7th August 2015) Authors: Williams, Bryan; MacDonald, Thomas M; Caulfield, Mark; Cruickshank, J Kennedy; McInnes, Gordon; Sever, Peter; Webb, David J; Salsbury, Jackie; Morant, Steve; Ford, Ian; Brown, Morris J Journal: BMJ open Issue: Volume 5:Issue 8(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Issue 10008 (21st November 2015) Authors: Williams, Bryan; MacDonald, Thomas M; Morant, Steve; Webb, David J; Sever, Peter; McInnes, Gordon; Ford, Ian; Cruickshank, J Kennedy; Caulfield, Mark J; Salsbury, Jackie; Mackenzie, Isla; Padmanabhan, Sandosh; Brown, Morris J Journal: Lancet Issue: Volume 386:Issue 10008(2015) Page Start: 2059 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗